VI
VivoSim Labs, Inc.
VIVS · NASDAQ
$0.25 +8.71% (+$0.02)
1M -22.26%
Market Cap $583.1K
P/E Ratio -
Div. Yield -
ROE 612.23%
Bulios Fair Price
$0.37
49.0% upside
Trenutna cena
$0.25
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica VIVS trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
33 /100
Expensive P/S 5.21x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 29.26%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 134.82%
Net margin 11,016.10%
Op. margin 10,117.00%
Quality
0 /100
Poor ROIC 499.37%
ROE 612.23%
ROA 320.72%
Debt
36 /100
Moderate Current ratio 1.70x
Int. coverage -1,026.75x
Debt/Equity N/A
Stability
10 /100
Unstable Beta 1.45x
Rev. volatility 51.66%
EPS volatility 159.89%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VIVS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Keith Murphy
Employees
15
Headquarters
San Diego
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report